Literature DB >> 18551023

Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.

Hong Wang1, Tatsuo Shimosawa, Hiromitsu Matsui, Tomoyo Kaneko, Sayoko Ogura, Yuzaburo Uetake, Katsu Takenaka, Yutaka Yatomi, Toshiro Fujita.   

Abstract

BACKGROUND: Salt status plays a pivotal role in angiotensin-II-induced organ damage by regulating reactive oxygen species status, and it is reported that reactive oxygen species activate mineralocorticoid receptors.
METHOD: To clarify the role of reactive oxygen species-related mineralocorticoid receptor activation in angiotensin-II-induced cardiac dysfunction, we examined the effect of the following: salt status; an MR antagonist, eplerenone; and an antioxidant, tempol in angiotensin-II-loaded Sprague-Dawley rats.
RESULTS: Angiotensin-II/salt-loading elevated blood pressure, and neither eplerenone nor tempol antagonized the rise in blood pressure significantly. Left ventricular diastolic function was monitored by measuring peak velocity of a mitral early inflow (E), the ratio of mitral early inflow to atrial contraction related flow (E/A), deceleration time of mitral early inflow and -dP/dt, the time constant (T), and filling pressure (left ventricular end-diastolic pressure) by echocardiography or cardiac catheterization. Despite the suppressed serum aldosterone, left ventricular diastolic function was deteriorated with angiotensin II/high salt, but not affected by angiotensin II/low salt. However, angiotensin-II/salt-induced cardiac dysfunction was restored by eplerenone and tempol. Nicotinamide adenine dinucleotide phosphateoxidase-derived superoxide formation was greater in the hearts of the angiotensin II/high-salt rats than of the angiotensin II/low-salt rats. The expression of the Na(+) -H(+) exchanger isoform 1, a target of mineralocorticoid receptor activation, was significantly increased in the angiotensin II/high-salt group. Both tempol and eplerenone inhibited the angiotensin-II/salt-induced upregulation of Na(+) -H(+) exchanger isoform 1.
CONCLUSION: These findings demonstrate that mineralocorticoid receptor activation by oxidative stress can cause left ventricular diastolic dysfunction in a rat model of mild hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551023     DOI: 10.1097/HJH.0b013e328300a232

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  16 in total

Review 1.  Oxidative stress and organ damages.

Authors:  Sayoko Ogura; Tatsuo Shimosawa
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 2.  Genetics of hypertension and cardiovascular disease and their interconnected pathways: lessons from large studies.

Authors:  Aldi T Kraja; Steven C Hunt; D C Rao; Victor G Dávila-Román; Donna K Arnett; Michael A Province
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

3.  Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression.

Authors:  Javad Habibi; Vincent G DeMarco; Lixin Ma; Lakshmi Pulakat; William E Rainey; Adam T Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

Review 4.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

Review 5.  Resveratrol in cardiovascular disease: what is known from current research?

Authors:  Hong Wang; Yue-Jin Yang; Hai-Yan Qian; Qian Zhang; Hui Xu; Jian-Jun Li
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 6.  Impairment of Arterial Compliance in Cushing's Syndrome.

Authors:  Pier Paolo Bassareo; Angela Maria Zedda; Giuseppe Mercuro
Journal:  Eur Endocrinol       Date:  2014-08-28

Review 7.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

Review 8.  Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.

Authors:  Guido Lastra; Sonal Dhuper; Megan S Johnson; James R Sowers
Journal:  Nat Rev Cardiol       Date:  2010-08-10       Impact factor: 32.419

9.  Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.

Authors:  Adam Whaley-Connell; Javad Habibi; Nathan Rehmer; Sivakumar Ardhanari; Melvin R Hayden; Lakshmi Pulakat; Caroline Krueger; Carlos M Ferrario; Vincent G DeMarco; James R Sowers
Journal:  Metabolism       Date:  2013-01-24       Impact factor: 8.694

10.  Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?

Authors:  Michael Gekle; Claudia Grossmann
Journal:  Pflugers Arch       Date:  2008-11-19       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.